Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-155556
Filing Date
2019-05-23
Accepted
2019-05-23 17:31:02
Documents
1
Effectiveness Date
2019-05-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A d753699ddefa14a.htm DEFA14A 29068
  Complete submission text file 0001193125-19-155556.txt   30085
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 19851251
SIC: 2834 Pharmaceutical Preparations